Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Dersimelagon phosphate by Mitsubishi Tanabe Pharma for Systemic Sclerosis (Scleroderma): Likelihood of Approval
Dersimelagon phosphate is under clinical development by Mitsubishi Tanabe Pharma and currently in Phase II for Systemic Sclerosis (Scleroderma). According...
Data Insights
Dersimelagon phosphate by Mitsubishi Tanabe Pharma for Porphyria (Erythropoietic Protoporphyri): Likelihood of Approval
Dersimelagon phosphate is under clinical development by Mitsubishi Tanabe Pharma and currently in Phase III for Porphyria (Erythropoietic Protoporphyri). According...